Afuco™ Anti-Human CD55 ADCC Recombinant Antibody (PAT-SC1), ADCC Enhanced

CAT#: AFC-126CL

Anti-CD55 ADCC Enhanced Antibody (PAT-SC1) is an ADCC enhanced antibody produced by our Afuco™ platform. PAT-SC1 has a strong potential to be used as an additive therapeutic agent in the treatment of patients with gastric cancers. A study conducted between 1997 and 2001, a single 20mg dose of PAT-SC1 administered before gastric resection surgery induced cell killing in human primary gastric tumours. This led to tumour cell regression in over half of PAT-SC1-treated patients. In the 10 year follow-up study of patients that participated in the trial, survival is significantly higher for PAT-SC1 treated patients as compared to an historical control group of patients that underwent a gastric resection but were not treated with PAT-SC1.

Gene Expression
Figure 1 Cerebral cortex Figure 2 Lung Figure 3 Colon Figure 4 Testis Figure 5 RNA cell line category: Cell line enhanced (HeLa, HMC-1, PC-3, U-2197)

Specifications

  • Host Species
  • Human
  • Derivation
  • Human
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Related Disease
  • Cancer

Product Property

  • Purity
  • Purity>95% by SDS-PAGE
  • Storage
  • 4 °C, -20°C if preferred

Target

  • Alternative Names
  • CD55; CD55 molecule, decay accelerating factor for complement (Cromer blood group); CR; TC; DAF; CROM; complement decay-accelerating factor; CD55 antigen
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for AFC-126CL. Click the button above to contact us or submit your feedback about this product.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

See other products for "CD55"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
BRD-0102MZ Chicken Anti-CD55 Polyclonal IgY WB Chicken antibody
CAT Product Name Application Type
MOR-0570 Hi-Affi™ Rabbit Anti-CD55 Recombinant Antibody (clone DS570AB) WB, IHC Rabbit IgG
CAT Product Name Application Type
VS2-QX15 Mouse Anti-CD55 Recombinant Antibody (clone BRIC 128) IHC, WB Mouse IgM, κ
CAT Product Name Application Type
VS-0724-YC463 AbPlus™ Anti-CD55 Magnetic Beads (VS-0724-YC463) IP, Protein Purification
CAT Product Name Application Type
VS-1024-XY103 Mouse Anti-NHP CD55 Recombinant Antibody (clone MEM-118) IHC, FC Mouse IgM
CAT Product Name Application Type
VS-0325-FY204 Human Anti-CD55 (clone LU30) scFv-Fc Chimera FC, ELISA Human IgG1, scFv-Fc
CAT Product Name Application Type
VS-0425-YC184 Recombinant Anti-CD55 Vesicular Antibody, EV Displayed (VS-0425-YC184) ELISA, FC, Inhib, Cell-uptake
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare